Tearsheet

Innovate (VATE)


Market Price (7/9/2026): $11.6 | Market Cap: $154.8 MilSector: Industrials | Industry: Construction & Engineering

Innovate (VATE)


Market Price (7/9/2026): $11.6
Market Cap: $154.8 Mil
Sector: Industrials
Industry: Construction & Engineering

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 25%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%

Attractive yield
FCF Yield is 115%

Weak multi-year price returns
3Y Excs Rtn is -102%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 414%

Stock price has recently run up significantly
6M Rtn6 month market price return is 118%, 12M Rtn12 month market price return is 108%

Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.5%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 136%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39%

Key risks
VATE key risks include [1] significant "going concern" doubt from its auditor due to poor financial strength and ongoing profitability issues and [2] high stock volatility.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 25%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%
2 Attractive yield
FCF Yield is 115%
3 Weak multi-year price returns
3Y Excs Rtn is -102%
4 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 414%
5 Stock price has recently run up significantly
6M Rtn6 month market price return is 118%, 12M Rtn12 month market price return is 108%
6 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -2.5%
7 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 136%
8 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -39%
9 Key risks
VATE key risks include [1] significant "going concern" doubt from its auditor due to poor financial strength and ongoing profitability issues and [2] high stock volatility.

VATE in ETFs

Weight = VATE's share of each fund

VTI0.00%
IWM0.00%
IWO0.00%

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 7/8/2026

Innovate (VATE) stock has gained about 100% since 3/31/2026 because of the following key factors:

1. Strong Fiscal Q1 2026 Operational Performance, Driven by Infrastructure and Life Sciences.

Innovate (VATE) reported robust consolidated revenue growth of 33.0% year-over-year to $364.8 million for fiscal Q1 2026, which ended March 31, 2026. Total Adjusted EBITDA also saw a significant increase of 173.6% to $19.7 million from $7.2 million in the prior year's fiscal Q1. This performance was largely propelled by the Infrastructure segment (DBM Global Inc.), which recorded a 35.1% revenue increase to $357.9 million and an Adjusted EBITDA of $23.0 million, supported by a substantial adjusted backlog of $1.8 billion as of March 31, 2026. Concurrently, the Life Sciences segment achieved a notable milestone with MediBeacon receiving CE Mark approval in Europe for its Transdermal GFR Monitor and Reusable Sensor, indicating progress in its medical technology offerings.

2. Strategic Initiatives to Optimize Portfolio and Improve Financial Structure.

In fiscal Q2 2026, Innovate announced the successful closing of a refinancing for its Broadcasting segment and an agreement for a partial sale of Broadcasting on June 1, 2026. This strategic move, which included a $105 million loan and a 75% sale, aims to optimize the company's asset portfolio and potentially enhance its financial flexibility.

Show more
Updated on 7/8/2026

Innovate (VATE) stock has gained about 100% since 3/31/2026 because of the following key factors:

1. Strong Fiscal Q1 2026 Operational Performance, Driven by Infrastructure and Life Sciences.

Innovate (VATE) reported robust consolidated revenue growth of 33.0% year-over-year to $364.8 million for fiscal Q1 2026, which ended March 31, 2026. Total Adjusted EBITDA also saw a significant increase of 173.6% to $19.7 million from $7.2 million in the prior year's fiscal Q1. This performance was largely propelled by the Infrastructure segment (DBM Global Inc.), which recorded a 35.1% revenue increase to $357.9 million and an Adjusted EBITDA of $23.0 million, supported by a substantial adjusted backlog of $1.8 billion as of March 31, 2026. Concurrently, the Life Sciences segment achieved a notable milestone with MediBeacon receiving CE Mark approval in Europe for its Transdermal GFR Monitor and Reusable Sensor, indicating progress in its medical technology offerings.

2. Strategic Initiatives to Optimize Portfolio and Improve Financial Structure.

In fiscal Q2 2026, Innovate announced the successful closing of a refinancing for its Broadcasting segment and an agreement for a partial sale of Broadcasting on June 1, 2026. This strategic move, which included a $105 million loan and a 75% sale, aims to optimize the company's asset portfolio and potentially enhance its financial flexibility.

3. Significant Cash Inflow from DBM Global Dividend.

Subsequent to the reporting period, Innovate announced on July 8, 2026 (fiscal Q3 2026) that its Infrastructure subsidiary, DBM Global Inc., plans to pay a cash dividend of approximately $12 million. As DBM Global's largest stockholder, Innovate is expected to receive approximately $11 million from this payout, providing a substantial cash inflow. This highlights the ongoing strong performance and value generation from its core Infrastructure business.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 101.2% change in VATE stock from 3/31/2026 to 7/8/2026 was primarily driven by a 87.6% change in the company's P/S Multiple.
(LTM values as of)33120267082026Change
Stock Price ($)5.6811.43101.2%
Change Contribution By: 
Total Revenues ($ Mil)1,2461,3377.3%
P/S Multiple0.10.187.6%
Shares Outstanding (Mil)13130.0%
Cumulative Contribution101.2%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2026 to 7/8/2026
ReturnCorrelation
VATE101.2% 
Market (SPY)14.6%7.6%
Sector (XLI)11.6%16.7%

Fundamental Drivers

The 152.9% change in VATE stock from 12/31/2025 to 7/8/2026 was primarily driven by a 109.4% change in the company's P/S Multiple.
(LTM values as of)123120257082026Change
Stock Price ($)4.5211.43152.9%
Change Contribution By: 
Total Revenues ($ Mil)1,1001,33721.5%
P/S Multiple0.10.1109.4%
Shares Outstanding (Mil)1313-0.6%
Cumulative Contribution152.9%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 7/8/2026
ReturnCorrelation
VATE152.9% 
Market (SPY)9.6%10.4%
Sector (XLI)16.6%15.4%

Fundamental Drivers

The 121.9% change in VATE stock from 6/30/2025 to 7/8/2026 was primarily driven by a 80.1% change in the company's P/S Multiple.
(LTM values as of)63020257082026Change
Stock Price ($)5.1511.43121.9%
Change Contribution By: 
Total Revenues ($ Mil)1,0661,33725.4%
P/S Multiple0.10.180.1%
Shares Outstanding (Mil)1313-1.7%
Cumulative Contribution121.9%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2025 to 7/8/2026
ReturnCorrelation
VATE121.9% 
Market (SPY)21.7%8.5%
Sector (XLI)23.6%12.5%

Fundamental Drivers

The -34.2% change in VATE stock from 6/30/2023 to 7/8/2026 was primarily driven by a -41.8% change in the company's Shares Outstanding (Mil).
(LTM values as of)63020237082026Change
Stock Price ($)17.3711.43-34.2%
Change Contribution By: 
Total Revenues ($ Mil)1,5421,337-13.3%
P/S Multiple0.10.130.4%
Shares Outstanding (Mil)813-41.8%
Cumulative Contribution-34.2%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2023 to 7/8/2026
ReturnCorrelation
VATE-34.2% 
Market (SPY)74.1%17.9%
Sector (XLI)75.1%20.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
VATE Return13%-49%-34%-60%-9%202%-58%
Peers Return46%14%28%27%31%31%363%
S&P 500 Return27%-19%24%23%16%10%100%

Monthly Win Rates [3]
VATE Win Rate50%50%42%25%25%71% 
Peers Win Rate56%60%63%53%57%57% 
S&P 500 Win Rate75%42%67%75%67%57% 

Max Drawdowns [4]
VATE Max Drawdown-23%-83%-71%-73%-69%-33% 
Peers Max Drawdown-27%-28%-27%-29%-38%-25% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: DY, FLR, GVA, SHIM, PWR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/8/2026 (YTD)

How Low Can It Go

EventVATES&P 500
2025 US Tariff Shock
  % Loss-56.0%-18.8%
  % Gain to Breakeven127.4%23.1%
  Time to Breakeven315 days79 days
2024 Yen Carry Trade Unwind
  % Loss-27.2%-7.8%
  % Gain to Breakeven37.3%8.5%
  Time to Breakeven64 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-42.3%-9.5%
  % Gain to Breakeven73.3%10.5%
  Time to Breakeven928 days24 days
2020 COVID-19 Crash
  % Loss-67.7%-33.7%
  % Gain to Breakeven209.6%50.9%
  Time to Breakeven365 days140 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-22.6%-3.7%
  % Gain to Breakeven29.3%3.9%
  Time to Breakeven28 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-52.6%-12.2%
  % Gain to Breakeven111.1%13.9%
  Time to Breakeven343 days62 days

Compare to DY, FLR, GVA, SHIM, PWR

In The Past

Innovate's stock fell -56.0% during the 2025 US Tariff Shock. Such a loss loss requires a 127.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventVATES&P 500
2025 US Tariff Shock
  % Loss-56.0%-18.8%
  % Gain to Breakeven127.4%23.1%
  Time to Breakeven315 days79 days
2024 Yen Carry Trade Unwind
  % Loss-27.2%-7.8%
  % Gain to Breakeven37.3%8.5%
  Time to Breakeven64 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-42.3%-9.5%
  % Gain to Breakeven73.3%10.5%
  Time to Breakeven928 days24 days
2020 COVID-19 Crash
  % Loss-67.7%-33.7%
  % Gain to Breakeven209.6%50.9%
  Time to Breakeven365 days140 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-22.6%-3.7%
  % Gain to Breakeven29.3%3.9%
  Time to Breakeven28 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-52.6%-12.2%
  % Gain to Breakeven111.1%13.9%
  Time to Breakeven343 days62 days
2013 Taper Tantrum
  % Loss-33.0%-0.2%
  % Gain to Breakeven49.3%0.2%
  Time to Breakeven71 days1 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-33.2%-17.9%
  % Gain to Breakeven49.7%21.8%
  Time to Breakeven167 days123 days

Compare to DY, FLR, GVA, SHIM, PWR

In The Past

Innovate's stock fell -56.0% during the 2025 US Tariff Shock. Such a loss loss requires a 127.4% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Innovate (VATE)

Innovate Corp. (VATE) is a diversified holding company primarily operating across three distinct segments: infrastructure, life sciences, and spectrum (media). Its most significant operations center on the infrastructure sector, where it provides extensive industrial construction, structural steel fabrication, and facility maintenance services. The company serves a wide array of large-scale commercial, industrial, and public works projects, including buildings, hotels, stadiums, hospitals, dams, bridges, mines, refineries, and power plants across the United States.

Within its infrastructure segment, Innovate fabricates specialized products such as trusses, girders, water storage tanks, pressure vessels, and equipment for the oil, gas, petrochemical, and pipeline industries. It also offers integrated solutions including digital engineering, heavy equipment installation, and BIM modeling services. Beyond infrastructure, Innovate's life sciences division is dedicated to developing products for early osteoarthritis of the knee, as well as various aesthetic and medical technologies for skin treatment. Additionally, the company operates in the media space, managing over-the-air broadcasting stations and the Azteca America Spanish-language broadcast network.

AI Analysis | Feedback

Here are a few brief analogies to describe Innovate (VATE):

  • A mini-Berkshire Hathaway, holding diverse investments in heavy construction, life sciences, and broadcast media.

  • Imagine a scaled-down 3M or General Electric, with a unique portfolio spanning heavy industrial construction, medical technology, and broadcast media.

AI Analysis | Feedback

  • Industrial and Infrastructure Construction Services: Provides comprehensive services including industrial construction, structural steel fabrication, facility maintenance, digital engineering, and BIM modeling for diverse projects.
  • Specialized Fabrication: Fabricates large-scale components such as trusses, girders, water pipes, storage tanks, tunnel liners, and pressure vessels.
  • Heavy Equipment & Industry Solutions: Supplies equipment and offers integrated solutions for the oil, gas, petrochemical, and pipeline industries.
  • Life Sciences Products: Develops products for early osteoarthritis of the knee and offers aesthetic and medical technologies for skin treatment.
  • Broadcasting and Media Services: Operates over-the-air broadcasting stations and manages Azteca America, a Spanish-language broadcast network.

AI Analysis | Feedback

Based on the provided company description, Innovate (VATE) primarily sells to other companies (B2B) rather than individuals. The description does not list specific major customer company names. However, it indicates the following categories of customers it serves:

1. Commercial, Industrial, and Infrastructure Project Owners, Developers, and Contractors: This category includes various entities undertaking large-scale construction and infrastructure projects. Innovate provides services for projects such as:

  • Buildings and office complexes, hotels, casinos, convention centers, sports arenas, stadiums, shopping malls, and hospitals.
  • Dams, bridges, mines, metal processing facilities, refineries, pulp and paper mills, and power plants.
  • Companies in the oil, gas, petrochemical, and pipeline industries.

2. Healthcare Providers and Distributors: For its life sciences segment, Innovate develops products for early osteoarthritis of the knee and aesthetic and medical technologies for the skin. These products are typically sold to:

  • Hospitals, clinics, dermatologists, and other medical practices.
  • Distributors of medical devices and aesthetic technologies.

3. Advertisers: Innovate's spectrum segment operates over-the-air broadcasting stations and the Azteca America Spanish-language broadcast network. The customers for this segment are businesses that purchase advertising time and services to reach their target audiences.

AI Analysis | Feedback

null

AI Analysis | Feedback

Paul K. Voigt, Interim Chief Executive Officer

Paul K. Voigt was named Interim Chief Executive Officer of INNOVATE Corp. effective July 25, 2023. Prior to this role, he served as Senior Managing Director of Investments at Lancer Capital starting in 2019. From 2014 to 2018, Mr. Voigt was Senior Managing Director of Investments at INNOVATE (formerly HC2), where he was instrumental in capital raising and transaction sourcing. His earlier career includes serving as Executive Vice President on the sales and trading desk at Jefferies from 1996 to 2013 and as Managing Director on the high yield sales desk at Prudential Securities from 1988 to 1996. Mr. Voigt earned a B.S. in electrical engineering from the University of Virginia and an MBA from the University of Southern California.

Michael J. Sena, Chief Financial Officer, Corporate Secretary

Michael J. Sena serves as the Chief Financial Officer and Corporate Secretary for INNOVATE Corp. He has held the position of Director of Finance/CFO since May 31, 2015. Mr. Sena is actively involved in the company's financial operations, including discussions on earnings calls regarding revenue and adjusted EBITDA for segments like Infrastructure, and refinancing transactions to extend debt maturities.

AI Analysis | Feedback

The key risks to Innovate (VATE) include significant liquidity concerns and upcoming debt maturities, the cyclical and margin-pressured nature of its infrastructure business, and challenges in divesting non-core assets and the declining performance of its spectrum segment.

  1. Liquidity and Debt Maturity Risk: Innovate Corp. faces substantial liquidity challenges and a highly leveraged capital structure. S&P Global Ratings downgraded the company's credit rating, citing weak liquidity and concerns about its ability to fund interest payments on corporate debt, with significant maturities looming in 2025 and 2026. More recently, in March 2026, S&P Global Ratings further lowered Innovate's rating to 'CCC-', indicating an elevated risk of a near-term default or distressed exchange due to limited financial flexibility and insufficient liquidity to meet upcoming obligations. The company has initiated a formal sale process for DBM Global, its key operating subsidiary, to comply with debt covenants, and there is uncertainty whether the proceeds from this sale would be sufficient to cover all of Innovate's outstanding debt obligations.
  2. Economic Sensitivity, Cyclicality, and Margin Compression in the Infrastructure Segment: Innovate's Infrastructure business, primarily DBM Global, is susceptible to revenue fluctuations influenced by project timing and broader economic cycles. This segment experienced revenue decreases in Q1 and Q2 2025. Despite a strong project backlog, the segment has reported gross margin compression, indicating pressure on profitability within its core operations.
  3. Challenges in Divesting Non-Core Assets and Declining Performance in the Spectrum Segment: Innovate is actively pursuing an exit strategy for its Life Sciences segment, which, despite having FDA-approved products and growth from a small base, is considered a non-core asset. Regulatory and market pressures could potentially depress the sale price or prolong the divestiture process. Additionally, the Spectrum segment continues to grapple with a challenging advertising environment, impacting its financial performance.

AI Analysis | Feedback

```html

For Innovate's spectrum/media segment (over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network), the clearest emerging threat is the continued growth and dominance of digital streaming services and online content platforms. These services compete directly for viewers and advertising revenue, leading to cord-cutting and a fundamental shift in media consumption habits away from traditional linear television broadcasting.

```

AI Analysis | Feedback

The addressable markets for INNOVATE Corp.'s main products and services are primarily within the U.S. and can be sized as follows:

Infrastructure

  • Industrial Building Construction: The U.S. Industrial Building Construction Market was valued at approximately USD 43.8 billion in 2024.
  • Commercial Construction: The U.S. commercial construction market size is estimated at USD 567.05 billion in 2026.
  • Structural Steel Fabrication: The U.S. structural steel market generated a revenue of approximately USD 7.6 billion in 2024. The broader Fabricated Structural Metal Manufacturing market in the U.S. was approximately USD 65.4 billion in 2024.
  • Facility Management Services: The United States facility management market was valued at approximately USD 365.93 billion in 2025.

Life Sciences

  • Early Osteoarthritis of the Knee Treatments: The U.S. knee osteoarthritis market size reached approximately USD 4.7 billion in 2023.
  • Aesthetic and Medical Technologies for the Skin: The U.S. medical aesthetics market is projected to reach USD 16.38 billion by 2030, growing from USD 7.62 billion in 2024.

Spectrum

  • Over-the-Air Broadcasting Stations: The U.S. television broadcast industry, including networks and individual stations, had combined annual revenue of about USD 60 billion.
  • Spanish-Language Broadcast Network (Azteca America): While a specific market size for Spanish-language broadcast networks is not distinctly separated from the broader broadcasting market, advertising revenue for linear Spanish-language networks in the U.S. reached approximately USD 1.5 billion between October 2021 and July 2022. The larger U.S. Television Services market was USD 117.68 billion in 2024.

AI Analysis | Feedback

Innovate (VATE) is expected to drive future revenue growth over the next 2-3 years through several key areas across its operating segments:

1. Continued Expansion of Life Sciences Segment through R2 Technologies' Glacial Systems

Growth in the Life Sciences segment is anticipated to be driven by the increasing sales and global expansion of R2 Technologies' Glacial systems, particularly the Glacial fx system. The company has reported strong increases in North American system sales, with significant year-over-year growth in 2023. Additionally, R2 Technologies is expanding its global reach, having received market approvals in new territories such as Saudi Arabia and the UAE. This expansion, coupled with a substantial increase in market awareness, social media impressions, provider location searches, and lead generation, is expected to fuel further sales of Glacial systems and consumables.

2. Conversion and Growth of Infrastructure Segment's Backlog and New Project Opportunities

The Infrastructure segment, primarily through DBM Global, is poised for revenue growth due to its expanding adjusted backlog. DBM Global's adjusted backlog, which includes awarded but not yet signed contracts, has shown significant growth, increasing by approximately $500 million to over $1.6 billion since the end of 2024. This substantial backlog indicates a pipeline of future revenue. The company also expects opportunities in industrial and modularization sectors of the market, as well as continued activity in large commercial construction projects and commercial structural steel fabrication and erection businesses.

3. Strategic Network Launches and Commercialization of ATSC 3.0 in the Spectrum Segment

The Spectrum segment is expected to contribute to revenue growth through strategic network launches and the commercial application of ATSC 3.0 technology. Recent initiatives include the January 1st network launches of The 365 and Outlaw, along with subsequent launches of new sports networks like Outdoor America, MTRSPT1, and SPEED SPORT TV. Furthermore, the company is engaging in operating and revenue share agreements with Public Broadcast stations to provide "lighthousing" and commercial applications for ATSC 3.0, driving increased network distribution revenues.

AI Analysis | Feedback

Share Repurchases

  • Innovate (VATE) reported no share buybacks for both 2025 and 2026.

Share Issuance

  • Innovate Corp. conducted a $19.0 million rights offering for its common stock, announced in February 2024 and extended through April 2024.
  • A 1-for-10 reverse stock split for Innovate's common stock became effective on August 2, 2024, reclassifying every ten shares into one new share.
  • The number of outstanding shares decreased from approximately 77.8 million in early 2022 to about 13.3 million as of February 2026, primarily due to the reverse stock split.

Inbound Investments

  • The company's $19.0 million rights offering in 2024 was backstopped by Lancer Capital LLC, an investment fund led by Avram A. Glazer, who is also the Chairman of Innovate's Board and its largest stockholder.

Outbound Investments

  • Innovate operates as a diversified holding company with key segments including Infrastructure (DBM Global), Life Sciences (Pansend), and Spectrum (HC2 Broadcasting).
  • In December 2025, MediBeacon® Next Generation TGFR™ System, a product from its Pansend Life Sciences segment, received FDA approval.
  • Azteca América, part of Innovate's Spectrum segment, ceased operations in October 2022.

Capital Expenditures

  • Innovate (VATE) reported $0 in Capital Expenditures for both 2025 and 2026.

Better Bets vs. Innovate (VATE)

Latest Trefis Analyses

Title
0ARTICLES

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

VATEDYFLRGVASHIMPWRMedian
NameInnovate Dycom In.Fluor Granite .Shimmick Quanta S. 
Mkt Price11.43426.7049.51143.523.67666.3396.52
Mkt Cap0.212.87.26.2-99.87.2
Rev LTM1,3376,25215,1854,637-30,1216,252
Op Inc LTM35483-430270-1,691270
FCF LTM175440-41302-1,682302
FCF 3Y Avg78191204251-1,484204
CFO LTM2066729434-2,379434
CFO 3Y Avg102437308385-2,080385

Growth & Margins

VATEDYFLRGVASHIMPWRMedian
NameInnovate Dycom In.Fluor Granite .Shimmick Quanta S. 
Rev Chg LTM25.4%29.8%-8.3%14.9%-21.1%21.1%
Rev Chg 3Y Avg-2.5%16.6%2.1%13.1%-19.8%13.1%
Rev Chg Q33.0%56.1%-8.0%30.4%-26.3%30.4%
QoQ Delta Rev Chg LTM7.3%12.7%-2.1%4.8%-5.8%5.8%
Op Inc Chg LTM-13.1%40.2%-197.5%33.6%-21.6%21.6%
Op Inc Chg 3Y Avg97.2%24.2%320.2%113.0%-26.0%97.2%
Op Mgn LTM2.6%7.7%-2.8%5.8%-5.6%5.6%
Op Mgn 3Y Avg2.9%7.6%0.8%4.1%-5.5%4.1%
QoQ Delta Op Mgn LTM0.3%0.1%-1.0%-0.1%-0.0%0.0%
CFO/Rev LTM15.4%10.7%0.1%9.4%-7.9%9.4%
CFO/Rev 3Y Avg7.6%8.3%1.9%9.3%-8.2%8.2%
FCF/Rev LTM13.1%7.0%-0.3%6.5%-5.6%6.5%
FCF/Rev 3Y Avg5.8%3.4%1.2%6.1%-5.9%5.8%

Valuation

VATEDYFLRGVASHIMPWRMedian
NameInnovate Dycom In.Fluor Granite .Shimmick Quanta S. 
Mkt Cap0.212.87.26.2-99.87.2
P/S0.12.00.51.3-3.31.3
P/Op Inc4.326.5-16.823.2-59.023.2
P/EBIT4.226.4-26.618.6-57.418.6
P/E-2.941.120.733.8-90.333.8
P/CFO0.719.0803.214.4-42.019.0
Total Yield-34.7%2.4%4.8%3.1%-1.2%2.4%
Dividend Yield0.0%0.0%0.0%0.2%-0.1%0.0%
FCF Yield 3Y Avg112.8%2.5%3.3%7.0%-3.1%3.3%
D/E5.00.20.10.2-0.10.2
Net D/E4.10.2-0.40.2-0.10.2

Returns

VATEDYFLRGVASHIMPWRMedian
NameInnovate Dycom In.Fluor Granite .Shimmick Quanta S. 
1M Rtn-40.2%-7.0%-0.0%2.7%0.8%-3.9%-2.0%
3M Rtn40.9%12.0%0.7%14.1%-1.1%15.7%13.0%
6M Rtn117.7%20.4%11.5%20.5%7.6%52.6%20.4%
12M Rtn107.8%71.4%-3.4%55.6%84.4%76.6%74.0%
3Y Rtn-35.3%278.3%68.2%272.5%-42.7%245.4%156.8%
1M Excs Rtn-41.1%-9.8%2.8%0.3%-6.0%-5.5%-5.7%
3M Excs Rtn28.9%6.5%-9.3%5.8%-10.6%6.9%6.2%
6M Excs Rtn109.7%14.2%2.5%11.4%4.5%44.5%12.8%
12M Excs Rtn96.0%49.1%-25.2%33.7%76.7%52.8%50.9%
3Y Excs Rtn-102.4%207.3%-0.9%200.2%-110.8%172.3%85.7%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Infrastructure1,2101,0721,3971,5941,160
Spectrum2326223942
Life Sciences1210344
Non-operating Corporate00   
Other and Eliminations00   
Total1,2461,1071,4231,6371,205


Operating Income by Segment
$ Mil20252024202320222021
Infrastructure5566645835
Other and Eliminations-00   
Spectrum-01-3-4-1
Life Sciences-11-14-15-20-20
Non-operating Corporate-16-13-16-20-23
Other  -3-1-2
Total29402713-11


Assets by Segment
$ Mil20252024202320222021
Infrastructure759684851879786
Spectrum174179177188199
Life Sciences101281522
Non-operating Corporate71771525
Other and Eliminations00   
Other   5448
Total9508911,0441,1521,081


Price Behavior

Price Behavior
Market Price$11.43 
Market Cap ($ Bil)0.2 
First Trading Date07/13/2009 
Distance from 52W High-43.0% 
   50 Days200 Days
DMA Price$14.86$7.87
DMA Trendupup
Distance from DMA-23.1%45.2%
 3M1YR
Volatility105.3%86.8%
Downside Capture190.8990.75
Upside Capture255.14157.01
Correlation (SPY)5.5%7.8%
VATE Betas & Captures as of 6/30/2026

 1M2M3M6M1Y3Y
Beta-0.91-0.700.170.600.481.20
Up Beta-0.19-0.28-0.32-0.170.561.26
Down Beta-4.88-2.23-2.400.55-0.570.69
Up Capture173%149%492%348%213%210%
Bmk +ve Days11244067140429
Stock +ve Days13223869128347
Down Capture-72%-199%-166%-96%20%109%
Bmk -ve Days10172358112321
Stock -ve Days8192551114385

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VATE
VATE116.7%86.7%1.27-
Sector ETF (XLI)22.5%16.7%1.0412.4%
Equity (SPY)21.2%12.5%1.267.9%
Gold (GLD)21.9%27.8%0.704.8%
Commodities (DBC)25.0%18.7%1.06-5.7%
Real Estate (VNQ)12.7%13.9%0.626.8%
Bitcoin (BTCUSD)-41.4%42.8%-1.13-2.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VATE
VATE-21.0%94.8%0.15-
Sector ETF (XLI)13.8%17.6%0.6223.7%
Equity (SPY)13.2%17.1%0.6022.5%
Gold (GLD)17.8%18.3%0.796.3%
Commodities (DBC)7.8%19.5%0.303.8%
Real Estate (VNQ)2.8%18.9%0.0519.7%
Bitcoin (BTCUSD)12.1%53.5%0.415.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VATE
VATE-6.8%82.6%0.27-
Sector ETF (XLI)14.9%20.0%0.6627.5%
Equity (SPY)15.9%17.9%0.7626.5%
Gold (GLD)11.5%16.1%0.585.3%
Commodities (DBC)6.4%18.0%0.289.4%
Real Estate (VNQ)5.4%20.7%0.2223.6%
Bitcoin (BTCUSD)58.0%66.2%0.983.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date6152026
Short Interest: Shares Quantity0.2 Mil
Short Interest: % Change Since 53120261.3%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest3.6 days
Basic Shares Quantity13.3 Mil
Short % of Basic Shares1.8%

Earnings Returns History

Updated 7/8/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/14/2026-8.7%12.3%42.0%
3/26/202613.9%92.8%198.3%
11/12/20252.4%-8.4%-21.0%
8/5/2025-1.4%-18.8%-3.8%
5/6/2025-1.4%2.9%-9.3%
11/6/20240.4%-25.7%21.4%
8/7/2024-7.0%-10.8%-36.6%
5/7/2024-4.5%6.7%-11.5%
...
SUMMARY STATS   
# Positive999
# Negative141414
Median Positive5.8%3.7%21.4%
Median Negative-4.6%-8.9%-12.3%
Max Positive21.1%92.8%198.3%
Max Negative-26.4%-43.2%-43.2%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/14/2026-8.7%12.3%42.0%
3/26/202613.9%92.8%198.3%
11/12/20252.4%-8.4%-21.0%
8/5/2025-1.4%-18.8%-3.8%
5/6/2025-1.4%2.9%-9.3%
11/6/20240.4%-25.7%21.4%
8/7/2024-7.0%-10.8%-36.6%
5/7/2024-4.5%6.7%-11.5%
3/4/202421.1%-5.7%-7.2%
11/9/20236.5%0.0%8.4%
8/9/20237.7%-1.2%-12.5%
5/10/2023-26.4%-43.2%-43.2%
3/14/2023-1.3%2.7%-0.7%
11/2/2022-1.3%1.0%77.5%
8/3/2022-5.0%-9.4%-13.9%
5/4/2022-4.8%-21.0%-18.2%
3/9/20220.6%3.7%4.5%
11/4/20215.8%7.7%-12.1%
8/6/2021-1.8%-2.5%-7.9%
5/7/2021-9.5%-6.1%8.7%
3/10/2021-4.5%-2.6%9.7%
11/9/20204.2%-2.9%62.6%
8/10/2020-8.5%-11.4%-21.5%
SUMMARY STATS   
# Positive999
# Negative141414
Median Positive5.8%3.7%21.4%
Median Negative-4.6%-8.9%-12.3%
Max Positive21.1%92.8%198.3%
Max Negative-26.4%-43.2%-43.2%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/26/202610-K
09/30/202511/12/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202403/31/202510-K
09/30/202411/06/202410-Q
06/30/202408/07/202410-Q
03/31/202405/07/202410-Q
12/31/202303/06/202410-K
09/30/202311/09/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202203/14/202310-K
09/30/202211/02/202210-Q
06/30/202208/03/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/14/202610-Q
12/31/202503/26/202610-K
09/30/202511/12/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202403/31/202510-K
09/30/202411/06/202410-Q
06/30/202408/07/202410-Q
03/31/202405/07/202410-Q
12/31/202303/06/202410-K
09/30/202311/09/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202203/14/202310-K
09/30/202211/02/202210-Q
06/30/202208/03/202210-Q
03/31/202205/04/202210-Q
12/31/202103/09/202210-K
09/30/202111/04/202110-Q
06/30/202108/06/202110-Q
03/31/202105/07/202110-Q
12/31/202003/10/202110-K
09/30/202011/09/202010-Q
06/30/202008/10/202010-Q
03/31/202005/11/202010-Q
12/31/201903/16/202010-K
09/30/201911/05/201910-Q
06/30/201908/08/201910-Q
Core Cache Last Updated: 7/8/2026